Brief: Grand Pharmaceutical Says Unit Entered Into Huachen Biotech Supply Agreement
09/12/2021 10:18
Dec 9 (Reuters) - Grand Pharmaceutical:
* UNIT ENTERED INTO HUACHEN BIOTECH SUPPLY AGREEMENT
* HUACHEN BIOTECH SHALL SUPPLY GLYCINE, OTHER RAW MATERIALS
FOR
PHARMACEUTICAL USE TO HEBEI HUAYANG
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement